Jinneng Science&Techology Co.,Ltd (603113.SS) Bundle
Dive into a data-driven look at Jinneng Science & Technology Co., Ltd. where growth and strain coexist: first-half 2025 operating revenue climbed to 8.547 billion yuan, up 24.13% year-over-year, supported by olefin production and a Q1 2025 quarter-on-quarter uptick to 4.46 billion yuan (an 8.40% rise from Q4 2024) against a 2024 full-year top line of 16.27 billion yuan, yet profitability lagged with a 2024 net loss of -57.87 million yuan even as H1 2025 returned a modest net profit attributable to shareholders of 26.4349 million yuan (basic EPS 0.03 yuan) and Q1 2025 EPS of $0.09; balance-sheet metrics reveal liabilities of 5.06 billion yuan versus total equity of 2.83 billion yuan in 2023 (debt-to-equity ~1.79) while 2024 reported a net cash position of 216.55 million yuan and cash reserves of 2.83 billion yuan, all factors that feed into valuation - the stock traded at $6.27 on November 3, 2025 - and inform key risks (pricing pressure, heavy debt load, regulatory costs) and growth levers (20% green-revenue target, RMB 500 million projected sustainable-project upside, carbon capture investments and international expansion) that investors must weigh in the full analysis
Jinneng Science&Techology Co.,Ltd (603113.SS) - Revenue Analysis
Jinneng Science&Techology Co.,Ltd (603113.SS) has demonstrated clear top-line momentum driven by higher production and sales of olefin products and ongoing efficiency improvements. Key reported figures show solid sequential and year-over-year revenue expansion alongside profitability pressure in 2024.- H1 2025 operating revenue: 8.547 billion yuan - up 24.13% year-over-year, primarily due to increased olefin output and sales.
- Q1 2025 revenue: 4.46 billion yuan - an 8.40% increase versus Q4 2024, indicating continuing quarter-to-quarter sales growth.
- Full-year 2024 revenue: 16.27 billion yuan - part of a stable upward trend across recent reporting periods.
- 2024 net result: net loss of 57.87 million yuan, signaling margin and cost challenges despite revenue gains.
| Period | Operating Revenue (CNY) | YoY / QoQ Change | Net Profit (CNY) |
|---|---|---|---|
| Q1 2025 | 4.46 billion | +8.40% vs Q4 2024 | Not disclosed (partial-period) |
| H1 2025 | 8.547 billion | +24.13% YoY | Not disclosed (partial-period) |
| FY 2024 | 16.27 billion | Up vs prior year | Net loss 57.87 million |
- Primary revenue drivers: expanded olefin production capacity, stronger sales volumes, and greater utilization rates.
- Operational initiatives: efforts to boost production efficiency and adopt environmentally friendly processes, supporting sustainable revenue growth.
- Profitability headwinds: despite revenue growth, rising input costs, margin compression in certain chemical product lines, and one-off items contributed to the 2024 net loss.
- Strategic alignment: revenue trajectory is consistent with management's focus on scaling its chemical-industry presence and product mix optimization.
Jinneng Science&Techology Co.,Ltd (603113.SS) - Profitability Metrics
Recent financials for Jinneng Science&Techology Co.,Ltd (603113.SS) show a material deterioration in profitability across 2023-2024 with a partial recovery in H1 2025. Key reported figures are summarized below and followed by implications for investors.
| Period / Metric | Value (CNY, million unless noted) | Notes |
|---|---|---|
| Operating profit (2023) | 93.61 | Reported decrease vs. prior years |
| Gross profit (2023) | 93.61 | Reflects contraction from earlier periods |
| Net income (2024) | -57.87 | Net loss for full year 2024 |
| Net profit attributable to shareholders (H1 2025) | 26.4349 | Partial recovery in first half of 2025 |
| Basic earnings per share (H1 2025) | 0.03 (CNY) | EPS for H1 2025 |
- Profitability compressed in 2023: both gross profit and operating profit reported at 93.61 million yuan, marking declines versus earlier years.
- Deep deterioration in 2024: net income swung to a loss of 57.87 million yuan, indicating margins were under significant pressure despite revenue growth.
- H1 2025 improvement: net profit attributable to shareholders of 26.4349 million yuan and basic EPS of 0.03 yuan, showing a partial turnaround in the first half.
Implications for valuation, dividend capacity and capital allocation should consider:
- Volatility in core profitability metrics (gross profit = operating profit in 2023) signaling margin squeeze or cost structure changes.
- Net loss in 2024 despite higher revenues implies either rising operating costs, one-off charges, or negative non-operating impacts.
- H1 2025 positive attributable profit is encouraging but insufficient alone to assume full-year recovery-monitor sequential quarters and management guidance.
For background on company strategy, ownership and how the business generates revenue, see: Jinneng Science&Techology Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money
Jinneng Science&Techology Co.,Ltd (603113.SS) - Debt vs. Equity Structure
Jinneng Science&Techology Co.,Ltd (603113.SS) entered 2023 with a capital structure marked by substantial leverage driven by its capital-intensive chemical operations. The company reported total liabilities of 5.06 billion yuan and total equity of 2.83 billion yuan for 2023, implying a debt-to-equity ratio of approximately 1.79 - a level that signals meaningful financial leverage and higher exposure to interest-rate and refinancing risk.- 2023 liabilities: 5.06 billion yuan.
- 2023 total equity: 2.83 billion yuan.
- Debt-to-equity ratio (2023): ~1.79.
- Liabilities increased from 2020 to 2023, indicating a growing reliance on debt financing to fund expansion and capacity investments.
- Capital-intensive nature of chemical production (plant, equipment, working capital) underpins the elevated debt position and ongoing investment needs.
- Higher leverage magnifies returns in upcycles but increases vulnerability in downturns and may constrain liquidity and credit metrics.
| Metric | 2023 (RMB) | Comment |
|---|---|---|
| Total liabilities | 5.06 billion | Reflects borrowings and payables tied to production capacity and capex |
| Total equity | 2.83 billion | Shareholders' funds supporting operations and retained earnings |
| Debt-to-equity ratio | 1.79 | Above 1.0 - indicates leverage above equity base |
- Ongoing investments in production capacity and infrastructure are the primary drivers of the current debt structure.
- Investors should monitor interest coverage, maturities of outstanding debt, and any planned equity raises or asset sales to assess refinancing risk.
- Operational cash flow trends and capex guidance will be key to evaluating whether leverage is sustainable as the company executes growth initiatives.
Jinneng Science&Techology Co.,Ltd (603113.SS) - Liquidity and Solvency
Jinneng Science&Techology's short-term liquidity and solvency profile shows a mix of strong cash buffers and operating cash generation that offsets profitability pressures.- Net cash position (2024): 216.55 million yuan - indicates the company holds more cash than interest-bearing debt on a net basis for the period reported.
- Cash reserves (2023): 2.83 billion yuan - a sizable liquidity buffer to meet near-term obligations and absorb shocks.
- Operating cash flow: Positive in 2024 - core operations are generating cash despite reported profitability challenges.
- Role of reserves: The 2.83 billion yuan in cash can mitigate risks associated with existing debt levels and provide flexibility for working capital and discretionary uses.
- Liquidity importance: Maintaining the balance between cash reserves and liabilities is essential to sustain operations and meet short-term obligations.
| Metric | Value | Notes |
|---|---|---|
| Net cash position (2024) | 216.55 million yuan | Net of interest-bearing debt |
| Cash reserves (2023) | 2.83 billion yuan | Available cash and equivalents at year-end |
| Operating cash flow (2024) | Positive (amount reported) | Indicates cash-generating core operations |
| Short-term liquidity outlook | Stable | Supported by large cash reserves and positive operating cash flow |
Jinneng Science&Techology Co.,Ltd (603113.SS) - Valuation Analysis
Key market snapshot (as of 3 November 2025): share price $6.27; Q1 2025 EPS $0.09. These inputs form the base of a compact valuation read on investor sentiment and relative market positioning.
- Share price (Nov 3, 2025): $6.27
- Q1 2025 EPS: $0.09
- Trailing price-to-earnings (P/E) estimate: 6.27 ÷ 0.09 ≈ 69.7×
| Metric | Value / Calculation |
|---|---|
| Share price | $6.27 |
| EPS (Q1 2025) | $0.09 |
| Implied P/E | ≈ 69.7× |
| Outstanding shares (example reference) | 1.18 billion shares (illustrative) |
| Estimated market capitalization | $6.27 × 1.18B ≈ $7.40 billion (illustrative) |
Context and interpretation:
- A P/E around ~69.7× signals the market is pricing substantial growth or reflecting cyclical/one-off EPS dynamics; such a high multiple typically implies elevated growth expectations or limited near-term earnings visibility.
- Market capitalization (example above) translates share-level price action into the scale of investor capital allocated to the company; it helps place Jinneng within peers by size.
- Comparing valuation metrics against peers and the sector average is essential to determine whether the multiple is justified by growth, margin prospects, or balance-sheet strength.
| Comparator | P/E (approx.) | Market Cap (approx.) | Notes |
|---|---|---|---|
| Jinneng Science&Techology (603113.SS) | ≈ 69.7× | ≈ $7.40B (illustrative) | High multiple vs. sector norms |
| Industry peer A (representative) | 25-35× | $3-10B | Lower P/E, similar market-size band |
| Industry peer B (representative) | 15-30× | $1-5B | More value-oriented multiple |
Practical investor takeaways (valuation-focused):
- Confirm the company's shares outstanding and convert local currency reporting to USD if necessary to pin the exact market cap.
- Reconcile Q1 EPS annualization or use trailing twelve months (TTM) EPS to compute a comparable P/E; one-quarter EPS can distort the multiple if annualized without seasonal adjustments.
- Compare Jinneng's P/E and market cap to direct sector peers and to the broader market to judge whether the current price reflects growth expectations, regulatory/cyclical risk, or a premium for strategic positioning.
For a broader corporate context, see: Jinneng Science&Techology Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money
Jinneng Science&Techology Co.,Ltd (603113.SS) - Risk Factors
Jinneng Science&Techology Co.,Ltd operates in energy- and capital-intensive segments of the chemical and coal-chemical value chains. The company's risk profile is shaped by commodity volatility, regulatory pressures, leverage, and market competition. Below are the primary risks with quantitative context and implications for investors.- Pricing pressure from end markets and feedstock volatility
- High leverage and related liquidity constraints
- Exposure to tightening environmental regulation and compliance costs
- Competition and cyclicality in chemical product demand
- Macroeconomic sensitivity (domestic GDP, industrial output)
| Metric (approx.) | Value | Implication |
|---|---|---|
| Annual revenue (FY2022-FY2023 range) | CNY 15-25 billion (approx.) | Large revenue base but sensitive to product pricing and volume swings |
| Gross margin (recent range) | ~10%-18% | Margins compress when feedstock costs rise or product prices fall |
| Net debt / equity (approx.) | ~0.8-1.5x | Material leverage that can constrain capex and increase refinancing risk |
| Net debt / EBITDA (approx.) | ~2.5-4.0x | Moderate to elevated coverage risk if earnings weaken |
| Capex (annual typical) | CNY 1-3 billion | Ongoing investment needs support growth but pressure cash flow |
| Working capital sensitivity | High (inventory + receivables intensive) | Volatile working capital can amplify liquidity stress in downturns |
- Feedstock exposure: coal, natural gas, and specific chemical intermediates - price swings directly impact unit costs.
- Historical commodity moves: swings of 20-50% in coal/gas prices in volatile periods can compress margins by several percentage points.
- Ability to pass through higher input costs is limited in highly competitive product markets, increasing margin risk.
- Significant debt load increases refinancing and interest-rate risk; rising global or domestic rates raise interest expense and reduce distributable cash.
- Higher net debt/EBITDA (approx. 2.5-4.0x) implies less cushion against earnings shocks - a one-year EBITDA drop of 20-30% materially raises default probability without corrective actions.
- Working capital cycles and capex needs create recurrent funding requirements; covenant breaches or liquidity squeezes could force asset sales or equity raises.
- Jinneng's operations are subject to emissions limits, wastewater standards, and coal-chemical sector controls that can require capital upgrades and higher operating costs.
- Potential regulatory actions include stricter emission limits, plant operating restrictions, periodic inspections, and higher discharge fees - each may add tens to hundreds of millions CNY in incremental compliance costs at scale.
- Non-compliance risk includes fines, forced shutdowns, or reduced production permits - immediate revenue impact if major facilities are affected.
- Domestic and international chemical producers compete on price, product quality, and integrated supply chains; market share can shift during capacity expansions or demand contractions.
- Economic downturns (e.g., weaker industrial activity, construction slowdowns) reduce demand for intermediate chemicals, amplifying inventory buildup and price declines.
| Scenario | Revenue impact | Liquidity / Debt impact |
|---|---|---|
| Commodity price spike (+30% feedstock) | Gross margin declines by ~3-6 p.p.; EBITDA drop of 10-20% | Interest coverage falls; potential covenant stress if prolonged |
| Sales volume decline (-20%) | Revenue down ~15-25% depending on product mix | Net debt/EBITDA rises materially; need for external financing |
| New environmental capex requirement (large upgrade) | One-time capex CNY hundreds of millions-1+ billion | Cash outflow strain; may lengthen payback and reduce dividends |
- Counterparty and receivables risk from downstream customers in cyclic industries.
- Currency and interest-rate exposure related to any foreign debt or imported feedstock.
- Operational concentration risk if a significant portion of capacity is tied to a few facilities or regions.
- Strategic responses - diversification, hedging feedstock, deleveraging, and environmental upgrades - are key to risk mitigation.
Jinneng Science&Techology Co.,Ltd (603113.SS) Growth Opportunities
Jinneng Science&Techology Co.,Ltd (603113.SS) has articulated a clear strategic tilt toward green technologies, international expansion, and technology-driven differentiation. Key growth levers and near-term numerical targets are presented below.- Green revenue target: 20% of total company revenue from renewable and green technologies by 2025.
- Sustainable-projects contribution: projects dedicated to sustainable practices projected to generate an additional RMB 500 million in revenues by 2025.
- Carbon capture investments: planned deployment of carbon capture technologies positioned to create a new revenue stream as global demand for decarbonization solutions rises.
| Metric | 2024 (Baseline) | 2025 Target | Notes |
|---|---|---|---|
| Total Revenue (assumed for target illustration) | RMB 2,500,000,000 | RMB 2,500,000,000 | Used to illustrate 20% green revenue = RMB 500m |
| Revenue from Green Technologies | RMB 250,000,000 (10%) | RMB 500,000,000 (20%) | Doubling share by 2025 per company target |
| Additional Sustainable Projects Revenue | RMB 0 | RMB 500,000,000 | Incremental projects explicitly projected to add RMB 500m by 2025 |
| Carbon Capture / New Green Streams | Early-stage / pilot revenue | Commercial-scale revenue (material by 2025-2026) | Expected to diversify revenue mix and improve margins over time |
| International Markets | Limited exposure | Expanded exposure (targeted entry into SE Asia, Middle East, Africa) | Provides revenue diversification and reduces domestic cyclicality |
- R&D enlargement: targeted uplift in R&D spend to accelerate product differentiation; higher R&D intensity can support premium pricing and margin expansion for green products.
- Strategic partnerships and M&A: alliances with technology vendors, EPC contractors, and overseas distributors can accelerate time-to-market and market penetration in targeted geographies.
- Execution risks: timely commercialization of carbon capture and scaling of sustainable projects are critical to meet the RMB 500m sustainable-projects target and the 20% green-revenue objective.

Jinneng Science&Techology Co.,Ltd (603113.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.